Lakefront Biotherapeutics is a clinical-stage biotechnology company developing innovative medicines that transform patient outcomes. Guided by scientific expertise, execution excellence, disciplined capital allocation, and long-term value creation, we advance programs that address significant unmet needs.
We identify, access, and advance high-quality assets in areas of high unmet need.
Our approach combines disciplined deal-making, rigorous analysis, and agile execution to identify, secure, and rapidly advance opportunities with clear potential to deliver meaningful patient impact and long-term shareholder value.